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Abstract 
While pathogenic bacteria contribute to a large number of globally important diseases and 
infections, current clinical diagnosis is based on processes that often involve culturing which 
can be time-consuming. Therefore, innovative, simple, rapid and low-cost solutions to 
effectively reduce the burden of bacterial infections are urgently needed. Here we 
demonstrate a label-free sensor for fast bacterial detection based on metal–oxide–
semiconductor field-effect transistors (MOSFETs). The electric charge of bacteria binding to 
the glycosylated gates of a MOSFET enables quantification in a straightforward manner. We 
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show that the limit of quantitation is 1.9 × 10
5 CFU/mL with this simple device, which is 
more than 10,000-times lower than is achieved with electrochemical impedance spectroscopy 
(EIS) and matrix-assisted laser desorption ionisation time-of-flight mass spectrometry 
(MALDI-ToF) on the same modified surfaces. Moreover, the measurements are extremely 
fast and the sensor can be mass produced at trivial cost as a tool for initial screening of 
pathogens. 
 
Keywords: biosensors, BioFET, electrochemical impedance spectroscopy, MALDI-ToF, 
bacteria 
 
1. Introduction 
Bacterial infection has a profound impact on global health (Coates et al., 2002) and 
contributes to globally important diseases, such as tuberculosis, pneumonia, tetanus, typhoid 
fever, diphtheria, syphilis, and is the cause of high infant mortality rates in developing 
countries; bacterial infection is also believed to be responsible for more than 20% of human 
tumours worldwide (Brachman & Abrutyn, 2009; Stein, 2011). The methods by which 
bacteria are currently detected in routine clinical microbiology involve processes consisting 
of an initial sample growth step where all the species in a sample are cultured in a rich 
medium in order to obtain a sufficient mass for a subsequent analysis. The post-growth 
analysis allows isolation and characterisation of single species in a sample, usually by means 
of techniques such as staining, real-time polymerase chain reaction (RT-PCR), whole genome 
sequencing (WGS) and matrix-assisted laser desorption ionisation time-of-flight mass 
spectrometry (MALDI-ToF MS) (see e.g. Fournier et al., 2013 and references therein). 
Although elegant and effective alternative approaches to microorganism detection have been 
reported (Mannoor et al., 2012; Zourob et al., 2008; Ma et al., 2015), where single bacteria 
sensing could be achieved (Kang et al., 2014; Mohanty & Berry, 2008), the current ‘gold 
standard’ for clinicians is still represented by culturing methods, nucleic acid-based sensors, 
immunoassays and fluorescence-based techniques (Ahmed et al., 2014). Limitations on the 
adoption of new solutions for diagnosis include the complexity of the fabrication of new 
sensors, the complexity of assay implementation and sample processing, and the prohibitive 
costs of introducing new equipment to perform bacterial detection. In order to overcome such 
obstacles while simultaneously introducing improvements in the current diagnostics, simple, 
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readily available sensors must be developed. The introduction of fast, simple and low-cost 
sensors that could be easily employed in clinical laboratories would dramatically reduce both 
the time and the cost of current bacterial diagnosis. For instance, a device that is able to 
provide an initial screening of a sample at the initial growth stage with adequate detection 
regarding its pathogenicity would be able to confirm the need to perform more complex and 
expensive analysis. Given the status of national health systems worldwide and the ever 
present need to reduce the cost of public healthcare, only very inexpensive, easily fabricated 
devices that are able to perform in a rapid manner and with parallel screening would be 
currently capable of supporting effectively clinical microbiology. 
We here report on a label-free bacterial detection system using biologically-sensitive field-
effect transistors (BioFETs) (Poghossian & Schöning, 2014). The BioFETs were constructed 
by immobilising a bioreceptor layer onto an extended gate of a metal–oxide–semiconductor 
field-effect transistor (MOSFET). MOSFETs are ubiquitous electronic components that can 
easily and cheaply be expanded into arrays for high-throughput screening. BioFETs with 
extended gold gates have previously been used for the detection of DNA hybridisation 
(Estrela et al., 2005) and proteins (Estrela et al., 2010). In this study we demonstrate the 
detection of mannose-specific type 1 fimbrial Escherichia coli PKL1162 as a case study for 
MOSFET-based bacterial detection.  
Amongst pathogenic bacteria, uropathogenic Escherichia coli (UPEC) are responsible for 
urinary tract infections. UPEC is the most predominant uropathogen causing approximately 
80% of uncomplicated infections (Ronald, 2003). It is estimated that between 40-50% of 
females and 15% of males will develop urinary infections and the rate of recurrent infections 
has been reported to be as high as 30% (Foxman et al., 2000). In order to colonise the cells of 
the urinary conducts and trigger a disease, UPEC can exploit hair-like protein structures 
expressed on their surface (called fimbriae), which allow bacteria to firmly adhere on the 
cells' surface and not be washed away in the urinary flow. Lectin protein structures, that 
constitute fimbriae, are expressed in at least 9 out of 10 UPEC strains (Oelschlaeger et al., 
2002). As the specificity can vary towards different glycosylated surfaces, several 
carbohydrate-specific fimbriae have been found and, amongst them, mannose-specific type 1 
fimbriae is classified as one of the most commonly expressed (Hartmann & Lindhorst, 2011). 
The recognition event interests the glycosylated cell of the urinary tract and the mannose-
specific protein, called FimH, situated at the tip of the fimbrial rod of the pathogenic bacteria.  
4 
 
The electric charge of bacteria binding to the glycosylated gate of a MOSFET enables 
quantification in a straightforward manner. Both the charges on the membrane of the bacteria 
and the displacement of water and ions from the biolayer surface when a bacteria is present, 
disturbs significantly the electrochemical double layer capacitance, which causes a threshold 
potential shift on the BioFETs. Very low limits of detection can be obtained with the 
technique. As a comparison, the same electrodes were used for electrochemical impedance 
spectroscopy (EIS) and matrix-assisted laser desorption ionisation time-of-flight mass 
spectrometry (MALDI-ToF) – both techniques show significantly higher limits of detection 
than the BioFETs. 
 
2. Materials and methods 
2.1. Bacteria preparation 
Uropathogenic Escherichia coli strain PKL1162 was obtained by engineering the strain 
SAR18 with the plasmid pPKL174 (Reisner et al., 2003). The bacteria were grown overnight 
while shaking in an incubator at 37 ̊C in lysogen broth growing media. The bacteria were 
then harvested by centrifugation at 4000 rpm for 15 min at 4 °C. The pelleted bacterial cells 
were resuspended in 10 mL of PBS Buffer and harvested twice before a final resuspension in 
1 mL of PBS Buffer for their quantification and use. 
 
2.2. Electrode functionalisation and affinity capture assay 
A mixture of HS-(CH2)17-(OC2H4)3-OH and HS-(CH2)17-(OC2H4)6-OCH2COOH in a ratio 
1:4 was used for the SAM formation. The mixture, obtained by mixing 53 μL of HS-(CH2)17-
(OC2H4)6-OCH2COOH (0.476 mM, 0.2 mg/mL in DMSO) and 147 μL of HS-(CH2)17-
(OC2H4)3-OH (0.328 mM, 0.2 mg/mL in DMSO) was sonicated for 20 minutes and used for 
the overnight incubation with the electrodes at room temperature in a humidity chamber. 
Aminoethyl glycosides in PBS at the concentration of 50 mM were immobilised overnight in 
humidity chamber at room temperature overnight after activation of the carboxyl groups 
using a solution of EDC/sulfo-NHS at the concentration of 40 mM and 10 mM, respectively, 
for 1 hour. Once the glycosides were immobilised, a blocking step of the non-reacted sites 
was performed using a 10 mM ethanolamine aqueous solution at pH 8.5 for 20 minutes. The 
bacteria affinity capture was performed by incubating the electrodes at 37 °C for 1.5 hours.  
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Immobilised α-D-mannose was used to affinity capture uropathogenic Escherichia coli strain 
PKL1162 while 2-Acetamido-2-deoxy-α-D-galactopyranose (GalNAc) was used as a control 
glycan. A further control was performed by measuring the interaction between α-D-mannose 
and the Escherichia coli strain K12. 
The assay was carried out on in-house fabricated arrays of gold electrodes (100 nm thickness 
deposited on 20 nm of chromium on glass substrates by means of thermal evaporation 
through a shadow mask). 
 
2.3. Measurements set up 
The extended-gate FET sensor with gold thin film electrode consisted of two parts: (i) an 
array of gold electrodes, where bacteria were captured, and (ii) the FET structure, which 
transduces the binding events on the gold electrode into electrical signals. The extended gate 
was fabricated by connecting the Au electrodes, fixed in a reaction cell, to the gate of a 
MOSFET via a metal wire.  
The BioFET measurements were carried out connecting the in-house fabricated arrays of gold 
electrodes to the gate of an n-type MOSFET. The MOSFET readings were taken using an 
Agilent B1500A HR CMU Semiconductor Device Analyser.  
The bacterial detection is initially demonstrated by performing electrochemical impedance 
spectroscopy (EIS) capacitive measurements. The capacitance (C) indicates the capacity of a 
material to store charge (Q) due to a potential difference (V) and is given by the expression 
𝐶 =
𝑄
𝑉
, which, for a parallel plate capacitor, can be rewritten as 𝐶 =
𝜀𝑜𝜀𝑟𝐴
𝑑
, where 𝜀𝑜 is the 
permittivity of the vacuum, 𝜀𝑟 is the relative permittivity that depends on the material 
between the two plates having a surface area 𝐴 that are a distance 𝑑 from each other. The 
imaginary and real part of the complex capacitance (C’ and C” respectively) were calculated 
from the measured impedance using equation (1) (Formisano et al., 2015): 
𝐶∗ = 𝐶′ + 𝑗𝐶′′ =
1
𝑗𝜔𝑍
    (1) 
The percentage change of capacitance from each step where then calculated considering only 
the real part of the capacitance, 𝐶′, at the frequency where the absolute value of the 
imaginary value, 𝐶′′, has its relative minimum. This frequency was 10 Hz throughout the 
experiments. 
6 
 
For the EIS recordings, non-Faradaic measurements were carried out in a phosphate buffer 
saline (PBS) solution diluted 100 times (ionic strength equal to 1.62 mM) without redox 
markers. The same measurement solution conditions were applied for MOSFET readings.  
EIS measurements were taken in a three electrode system using an Ag/AgCl as reference 
electrode and applying a 10 mV AC signal superimposed to 0 mV DC bias voltage vs. the 
open circuit potential.  
The same electrodes were analysed by MALDI-ToF mass spectrometry. Since large area 
electrically conducting surfaces are needed for MALDI-ToF measurements, the back of the 
glass slides used for EIS and BioFET measurements were covered with silver paint or with a 
conductive aluminium tape (Weissenborn et al., 2012). In addition, gold MALDI plates (AB 
Sciex Ltd) were used as a platform containing self-assembled biorepulsive monolayers of 
functionalised alkanethiols to which several aminoethyl glycosides were covalently attached 
(Šardzík, R. et al., 2010) to alternatively compare measurements obtained from the BioFETs. 
 
3. Results and discussion 
In our work, specific glycan interactions were studied on electrodes modified with self-
assembled monolayers (SAMs). The functionalised electrodes were connected to the gates of 
n-channel enhancement MOSFET devices, hence generating BioFETs (Figure 1). 
Mannosides were immobilised on the electrodes and used to affinity capture uropathogeninc 
Escherichia coli strain PKL1162 (Reisner et al., 2003). The surface chemistry was previously 
optimised and monitored by MALDI-ToF to obtain maximum bacteria binding (Both et al., 
2014; Noble et al.; 2012; Šardzik et al., 2012; Zhi et al., 2008). 
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Figure1 - Working principle of the BioFET sensor. An array of evaporated gold electrodes 
placed in a flow cell is connected to the gate of a MOSFET. An external reference electrode 
is used to apply the gate voltage. The same electrodes were used for EIS and MALDI-ToF 
measurements. 
 
3.1. Impedance 
The bacterial detection was initially demonstrated by performing electrochemical impedance 
spectroscopy (EIS) capacitive measurements. The literature on capacitive sensors report both 
on positive (Carrara et al., 2009; Varshney & Li, 2008; Couniot et al., 2015a; Couniot et al., 
2015b) and negative changes in capacitance measurements (Webster et al., 2009; Li et al., 
2011) after target binding. However, the behaviour of the sensor is dependent on the 
electrode type, immobilisation strategies, SAM properties and type of molecules detected. 
Ethylene-glycol terminated SAMs have hydrophilic properties (Carrara et al., 2009; Ostuni et 
al., 1999) that lead to the entrapment of water molecules within the SAM chains. For our 
sensor this phenomenon prevents the displacement of the ions in solution that form the 
Helmholtz plane upon bacteria binding. As a result, the bacteria and the underlying layers 
cannot be modelled simply by a series of capacitors (or as a single capacitor characterised by 
an increased distance separation d between the plates). Rather, the binding event will 
augment the surface of the electrode-solution interface which is surrounded by the solvent 
molecules forming the Helmholtz plane. Therefore, this can be modelled as two capacitors in 
parallel where the first has a fixed value and the value of the second capacitor is characterised 
by larger numbers of both d and relative permittivity 𝜀𝑟 (Asami et al., 1980) and its extent 
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varies with the amount of bacteria bound onto the sugars on the gate of the BioFET. The 
combination of such factors following the bacterial adhesion to the glycosylated surface 
produce eventually a positive shift in the total capacitance. Exploiting the insulating 
properties of ethylene glycol-terminated SAMs (Carrara et al., 2009; Berggren et al., 2001), 
capacitive measurements are facilitated using non-Faradaic EIS. 
A concentration of Escherichia coli PKL1162 equal to 4.2 × 10
9 CFU/mL produced an 
increase in the capacitance of 18.6 ± 1.7% (Figure 2). The EIS capacitance change decreased 
to 4.1 ± 1.3% when a decreased amount of 4.2 × 10
6 cell/mL of Escherichia coli PKL1162 
were used as a target on mannose. The capacitance change follows approximately a Hill-type 
response of the form y = ymax c
n/(kn+cn) where c is the concentration with ymax=22.8±1.4%, 
n=0.429±0.039, k=(1.37±0.47)×108 CFU/mL and a R2 of 0.998 (although the small amount 
of data points needs to be taken into consideration when interpreting this R2 value). Below 
4.2 × 10
6 CFU/mL, the signal overlaps the values of capacitance change given by the negative 
control reactions, namely in presence of negative sugar probe (bacteria PKL1162 on GalNAc 
sugar), which produces a capacitance shift of 6.4 ± 2.6% and in presence of negative bacteria 
(K12 on mannose), which gives a capacitance change of 2.5 ± 1.7%. Absolute values of 
capacitance range from 118 to 132 nF for electrodes functionalised with α-mannoside and 
from 123 to 155 nF upon bacterial adhesion. 
 
 
Figure 2 - Bacterial detection performing EIS capacitive measurements. a) Complex 
capacitance Cole-Cole plots for an electrode before (black line, squares) and after (red line, 
circles) Escherichia coli PKL1162 binding. The inset shows a schematic equivalent circuit. 
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b) Changes of the real part of the complex capacitance vs. bacterial concentration. The line 
represents a fit to the data with a Hill-type response (R2= 0.998). 
 
The use of a diluted measurement solution (PBS 1:100) reduced the ionic strength from 162 
to 1.62 mM, which in turn, increased the Debye length from about 7.6 Å to 76 Å and 
improved the EIS detection by over five fold for the Escherichia coli PKL1162 concentration 
of 4.2 × 10
9 CFU/mL. 
 
3.2. BioFET measurements 
In the case of our BioFET, as in Figure 1, when the potential applied across the gate and the 
source (Vgs) is larger than the threshold voltage (Vth) of the device (Vgs>Vth), a conducting 
channel is formed between the source and the drain. Additionally, if a voltage is applied 
between the drain to source (Vds>0) a current (ID) begins to flow through the induced channel 
at the semiconductor. This condition of the device is known as the turn-on state where the 
electron-current (ID) enters the drain and exits the source. Any changes in Vgs modulate the 
conductivity of the channel and thereby alter ID. In the case of molecular interactions at the 
gate of the transistor, such as negatively charged Escherichia coli (Silhavy et al., 2010) 
captured by surface mannosides, the minimum Vgs required to bring the n-MOSFET in the 
turn-on state is increased and it can be measured as an evidence of the binding event. 
The negative charge of Escherichia coli produces a positive shift in the Vgs of the BioFET as 
can be seen in Figure 3a. Figure 3b presents the values of ΔVgs for different bacteria 
concentration. ΔVgs increases from 31.0 ± 11.9 mV to 115.2 ± 12.9 mV when the bacterial 
concentration increases from 1.9 × 10
5 CFU/mL to 4.2 × 10
9 CFU/mL. The voltage shift also 
follows a Hill-type response with ymax=150±23 mV, n=0.250±0.045, 
k=(4.26±6.03)×107 CFU/mL and a R2 of 0.990. The lower value for 1.9 × 10
5 CFU/mL is still 
distinguishable from the signals obtained both in the presence of bacteria non-specific to the 
immobilised sugar (ΔVgs = 8.7 ± 1.3 mV) and in the presence of a non-specific immobilised 
sugar (ΔVgs = 16.2 ± 1.5 mV). BioFET measurements have the additional advantage of being 
very fast: data can be recorded in less than a second. Although EIS measurements could be 
recorded at a single frequency, which greatly shortens the time of the experiment as 
compared to the whole spectrum acquisition, miniaturisation of the devices would require 
long measurement sampling in order to accurately measure small a.c. current signals. On the 
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contrary, BioFETs are inherently miniaturisable as the shift of the threshold voltage is a 
charge density effect and hence the signal to noise ratio is preserved for miniaturised 
electrodes. The data presented demonstrates that BioFETs can be used for the initial 
differentiation between pathogenic and non-pathogenic E. Coli in order to decide which 
samples to send for further analysis. 
 
 
Figure 3 - Bacterial detection using BioFETs. a) BioFET ID/Vgs characteristic for an electrode 
before (black line) and after (red line) Escherichia coli binding. b) Vgs changes vs. bacterial 
concentration. The line represents a fit to the data with a Hill-type response (R2= 0.990). 
Error bars represent the standard deviation for three separate electrodes. 
 
3.3. Scanning electron microscopy 
Proof of bacterial binding and of good anti-fouling properties of the surface towards non-
specific bacteria are confirmed by scanning electron microscopy (SEM). The SEM images in 
Figure 4 show surface bacterial coverage at different concentrations (from 4.2 × 10
9 to 
4.2 × 10
5 CFU/mL) as well as in the presence of negative controls. The SEM pictures for 
negative controls are congruent with both the EIS and BioFET signals, even though BioFETs 
exhibited the highest sensitivity detecting much smaller amounts of PKL1162. 
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Figure 4 - SEM microscopy pictures of the affinity capture assay. Binding of Escherichia coli 
PKL1162 at the concentration of 4.2 × 10
9 (a), 4.2 × 10
8 (b), 4.2 × 10
7 (c), 4.2 × 10
6 (d), 
4.2 × 10
5 (e), 4.2 × 10
4 (f), CFU/mL on α-mannose; Escherichia coli strain K12 at the 
concentration of 4.2 × 10
9 on α-mannose (g) and Escherichia coli strain PKL12 at the 
concentration of 4.2 × 10
9 on GalNAc (h). 
 
3.4. MALDI-ToF mass spectrometry 
Glycan functionalisation of SAMs was confirmed using MALDI- ToF MS on both gold 
arrays and on gold arrays evaporated on glass by direct surface ionisation (see Supplementary 
Information). Specific peaks situated at 12000 and 16000 m/z corresponding to MS 
fingerprint of Escherichia coli PKL1162 can be observed by performing MS on bacterial 
sample spotted on bare gold without SAM functionalisation (Figure 5a-Control). Such peaks 
were also detected in the affinity reaction not only when performing the measurements on 
gold arrays but also on the gold arrays evaporated on glass as it can be seen in Figure 5a. The 
specificity of α-D-mannose towards Escherichia coli strain PKL1162 is shown in the 
Supplementary Information where Escherichia coli PKL1162 peaks are only clearly visible 
after affinity capture and washing, when the gold electrodes are functionalised with α-D-
mannose but not with other sugars. Moreover, although SEM microscopy shows significant 
bacterial adhesion using samples of Escherichia coli PKL1162 diluted up to 
4.2 × 10
6 CFU/mL (Figure 4), a minimum concentration of 2.7 × 10
9 CFU/mL was required to 
produce observable peaks using MALDI-ToF on gold plate (Figure 5b). MALDI-ToF spectra 
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also showed absence of any significant non-specific attachment of Escherichia coli K12 on α-
mannose (Figure 5b, bottom image) as well as on other sugars (Supplementary Information).  
 
 
Figure 5 - MALDI-ToF spectra of the affinity capture assay. a) MALDI-ToF spectra of 
uropathogenic Escherichia coli PKL1162 after affinity capture on α-D-mannose covalently 
linked to gold electrodes evaporated on glass slides (top image), of Escherichia coli 
PKL1162 spotted on bare gold (middle plot) and Escherichia coli PKL1162 after affinity 
capture on α-D-mannose covalently linked to gold arrays (bottom image). The peaks at12000 
and 16000 m/z are diagnostic for Escherichia coli PKL1162. b) MALDI-ToF spectra 
responses for different concentrations of Escherichia coli PKL1162 on α-D-mannose. The 
analysis was performed on SAM-functionalised gold plates, Escherichia coli K12 was used 
as negative control and showed no peaks upon MS analysis. 
 
In Table 1 the time of measurements and the limit of quantitation (LOQ) of our BioFET are 
compared to the ones obtained by our EIS and MALDI-ToF measurements and show a 
significant improvement (over 100 fold) of readout time. In the EIS set up, the absence of 
redox molecules simplified the assay with respect to conventional Faradaic EIS experiments. 
However, the EIS signal is a resultant of combined – and often competing – effects of the 
variation of surface area coverage, relative permittivity and the distance between the 
electrode and the Helmholtz plane upon bacterial binding, which can hinder the detection of 
low levels of bacteria. 
 
a b
Gold array evaporated on glass
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Table 1. BioFET, MALDI-ToF MS and EIS are compared in terms of limits of quantitation 
(LOQ) and time for carrying out the measurements in this work. The comparison is obtained 
considering that the three techniques were used on the same electrodes. Therefore, 
immobilisation times of the electrodes as well as the bacterial growth are not considered as 
they are equal for all the assays here reported. 
Technique LOQ (CFU/mL) Time required for 
the measurement 
BioFET 1.9 × 105 ~ 2 s 
EIS 4.2 × 107 ~ 10 min 
MALDI-ToF MS 2.7 × 109 ~ 20 min 
 
These effects are not as significant in the case of BioFETs. Using the electrodes as extended 
gates for MOSFETs, the sensor response is mostly due to the bacterial charge, thereby 
resulting in an LOQ being improved by more than two orders of magnitude (Table 1).  
With respect to MS detection, the sensitivity of the BioFETs is four orders of magnitude 
greater, which, together with its significantly reduced cost when compared to a MALDI-ToF 
instrument (considering a similar price for the sensor array), confirms the value of our sensor. 
Although low limits of bacteria detection have been reported for other types of biosensors 
(Ahmed et al., 2014), the mass-production of MOSFETs and the ease of integration into 
multiplexed devices with commercial planar processes for large-scale circuitry using standard 
semiconductor technologies such as CMOS, which has already been widely demonstrated by 
their ubiquitous use in everyday applications, can allow multiple screening of samples 
without leading to a significant increase in the costs of the sensor. Each individual 
multiplexed chip can be mass produced at very low cost (typically below $1) and the use of 
glycosides instead of e.g. antibodies as recognition elements doesn't had significant costs to 
the biochips. Furthermore, the readout system is straightforward from an electronics point of 
view and can be produced at a fairly low cost (below $100). Obviously the fingerprint given 
by techniques such as MALDI-ToF or PCR is essential for obtaining detailed information 
such as antimicrobial susceptibility, virulence and intra-species typing (Didelot et al., 2012; 
Formisano et al., 2015). However, such evidence is only needed once the pathogenicity of a 
sample has been confirmed. The ability to use an initial low-cost screening to limit the need 
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for more accurate and expensive techniques would significantly optimise times and costs of 
the examinations. 
 
4. Conclusions 
With the BioFET sensor developed in this work we have specifically detected uropathogenic 
Escherichia coli strains expressing type 1 fimbriae, which are responsible for the great 
majority of urinary tract infections (Ronald, 2003). The FimH protein on the type 1 fimbriae 
binds to the α-D-linked mannoses on glycoproteins of urinary epithelial cells. The BioFET 
sensors are highly applicable for bacteria-glycan interactions by using other glycans as targets 
for protein recognition; for example terminal sialic acid on gastrointestinal human mucins can 
be recognised by H. pylori SabA adhesin (Mahdavi et al., 2002) while Vibrio cholerae GbpA 
ahesin mainly binds to GalNAc (Bhowmick et al., 2008).  
Upon the binding of bacteria to functionalised electrodes, charges at the membrane of the 
bacteria and the displacement of water and ions from the biolayer surface (due to the 
presence of the large bacteria), disturbs significantly the electrochemical double layer 
capacitance. This in turn causes a shift on the threshold potential of the BioFETs. The 
BioFET will provide a signal to any type of bacteria that binds to the functionalised 
electrodes. For example, in Gram-positive bacteria the negative charge is mostly due to the 
presence of negatively charged phosphate in teichoic acids – teichoic acids are linked to 
either the peptidoglycan or to the underlying plasma membrane. For Gram-negative bacteria, 
the outer bacterial wall is covered by phospholipids and lipopolysaccharides and the charge is 
mostly given by the strong negative charge of lipopolysaccharides. Furthermore all bacteria 
will cause displacement of water ions from the biolayer further changing the electrochemical 
double layer capacitance. 
In conclusion we have demonstrated a fast, effective and inexpensive sensor that can be used 
to support current clinical microbiology by providing high-throughput screening of 
pathogenic bacterial samples. Our technology can be easily implemented and would be 
performed after the enrichment step and before further advanced investigations so that 
additional time and costs can be saved in the area of traditional bacterial detection. The 
results show through the use of suitable molecular probes, the BioFETs can differentiate 
pathogens that can be used for multiplexed screening. The large volume production of such 
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chips will bring the assay price further down, making it an attractive proposition for pathogen 
screening in point of care applications.  
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